✦ LIBER ✦

Pleomorphic xanthoastrocytoma in elderly patients may portend a poor prognosis

✍ Scribed by Wai Hoe Ng; Tchoyoson Lim; Tseng Tsai Yeo

Book ID: 116674120
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 406 KB
Volume: 15
Category: Article
ISSN: 0967-5868
DOI: 10.1016/j.jocn.2006.09.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Respiratory involvement in toxic epiderm

Respiratory involvement in toxic epidermal necrolysis portends a poor prognosis that may not be reflected in SCORTEN

✍ J.S. Hague; J.M.R. Goulding; T.M.W. Long; B.C. Gee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

The presence of lymphovascular invasion

The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis

✍ Daniel Canter; Thomas Guzzo; Matthew Resnick; Laurie Magerfleisch; Seema Sonnad; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

Anti-BP180 autoantibodies as a marker of

Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients

✍ P. BERNARD; C. BEDANE; J-M. BONNETBLANC 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

The prognosis of bullous pemphigoid (BP), a disorder which usually affects elderly patients, is not well established and conflicting data have been reported about the mortality rate of the disease. Our objective in this study was to assess the clinical and immunological factors determining survival

Non-melanoma skin cancer may be a marker

Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma

✍ Henrik Hjalgrim; Morten Frisch; Hans H. Storm; Bengt Glimelius; Jakob Bøje Peder 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 2 views

According to recent results, patients with non-melanoma skin cancers are at increased risk of developing non-Hodgkin's lymphoma (NHL). The prognostic significance of this association is unknown. Two cohorts of patients with a first diagnosis of non-melanoma skin cancer and a subsequent diagnosis of

KRAS G>A mutation favors poor tumor diff

KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma

✍ Fu, Tao; Guzzetta, Angela A.; Jeschke, Jana; Vatapalli, Rajita; Dave, Pujan; Hoo 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 French ⚖ 930 KB

Phase II trial of vindesine and VP16-213

Phase II trial of vindesine and VP16-213 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer

✍ Simon G. Allan; Anna Gregor; Michael A. Cornbleet; Robert C. F. Leonard; John F. 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 320 KB

Forty-three previously untreated patients, all of whom had poor-prognosis small cell lung cancer and/or were greater than 65 years old, received treatment with vindesine and VP16-213. Thirteen patients had limited disease and 30 extensive disease. Response rates (CR + PR) of 86% (CR 29%) and 66% (CR